Stocksigma LogoStocksigma Logo

Sai Parenterals Q2 FY27 Consolidated Results and Corporate Actions

Sai Parenterals reported consolidated Q2 revenue from operations of ₹1,949.18 mn for the quarter ended 30th Sep'26, up 264.1% YoY from ₹535.28 mn and 9.1%

Sai Parenterals Q2 FY27 Consolidated Results and Corporate Actions

Sai Parenterals Ltd · Financial Result · 01 Nov 2026, 9:34 pm

Sai Parenterals Q2 FY27 Consolidated Results and Corporate Actions Sai Parenterals reported consolidated Q2 revenue from operations of ₹1,949.18 mn for the quarter ended 30th Sep'26, up 264.1% YoY from ₹535.28 mn and 9.1% QoQ from ₹1,786.72 mn. Profit after tax rose 65.5% YoY to ₹105.10 mn (Q1: ₹79.23 mn), with EPS at ₹2.38. The board approved acquiring the remaining 25% stake in SP Analytics for ₹25,000 to make it a wholly owned subsidiary by 31st Dec'26, and confirmed completing the 60% stake acquisition in Saicriti Pharma.

Original exchange filing (PDF)

More announcements from Sai Parenterals Ltd

All Sai Parenterals Ltd announcements